Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

Standard

Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells. / Chen, Ying; Xu, Shu-Chang; Duan, Rui-Dong.

I: Lipids in Health and Disease, Vol. 14, 130, 2015.

Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift

Harvard

Chen, Y, Xu, S-C & Duan, R-D 2015, 'Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.', Lipids in Health and Disease, vol. 14, 130. https://doi.org/10.1186/s12944-015-0137-8

APA

Chen, Y., Xu, S-C., & Duan, R-D. (2015). Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells. Lipids in Health and Disease, 14, [130]. https://doi.org/10.1186/s12944-015-0137-8

CBE

Chen Y, Xu S-C, Duan R-D. 2015. Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells. Lipids in Health and Disease. 14:Article 130. https://doi.org/10.1186/s12944-015-0137-8

MLA

Chen, Ying, Shu-Chang Xu, och Rui-Dong Duan. "Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.". Lipids in Health and Disease. 2015. 14. https://doi.org/10.1186/s12944-015-0137-8

Vancouver

Chen Y, Xu S-C, Duan R-D. Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells. Lipids in Health and Disease. 2015;14. 130. https://doi.org/10.1186/s12944-015-0137-8

Author

Chen, Ying ; Xu, Shu-Chang ; Duan, Rui-Dong. / Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells. I: Lipids in Health and Disease. 2015 ; Vol. 14.

RIS

TY - JOUR

T1 - Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.

AU - Chen, Ying

AU - Xu, Shu-Chang

AU - Duan, Rui-Dong

PY - 2015

Y1 - 2015

N2 - Sphingomyelin (SM) and cholesterol are two types of lipid closely related biophysically. Treating the cells with exogenous sphingomyelinase (SMase) induces trafficking of cholesterol from membrane to intracellular pools and inhibition of cholesterol synthesis. In the present work, we address a question whether increased cholesterol synthesis affects hydrolysis of SM by endogenous SMases.

AB - Sphingomyelin (SM) and cholesterol are two types of lipid closely related biophysically. Treating the cells with exogenous sphingomyelinase (SMase) induces trafficking of cholesterol from membrane to intracellular pools and inhibition of cholesterol synthesis. In the present work, we address a question whether increased cholesterol synthesis affects hydrolysis of SM by endogenous SMases.

U2 - 10.1186/s12944-015-0137-8

DO - 10.1186/s12944-015-0137-8

M3 - Article

C2 - 26493087

VL - 14

JO - Lipids in Health and Disease

JF - Lipids in Health and Disease

SN - 1476-511X

M1 - 130

ER -